These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 35298796)

  • 1. Microwave Ablation, Radiofrequency Ablation, Irreversible Electroporation, and Stereotactic Ablative Body Radiotherapy for Intermediate Size (3-5 cm) Unresectable Colorectal Liver Metastases: a Systematic Review and Meta-analysis.
    Nieuwenhuizen S; Dijkstra M; Puijk RS; Geboers B; Ruarus AH; Schouten EA; Nielsen K; de Vries JJJ; Bruynzeel AME; Scheffer HJ; van den Tol MP; Haasbeek CJA; Meijerink MR
    Curr Oncol Rep; 2022 Jun; 24(6):793-808. PubMed ID: 35298796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unresectable Intermediate-Size (3-5 cm) Colorectal Liver Metastases: Stereotactic Ablative Body Radiotherapy Versus Microwave Ablation (COLLISION-XL): Protocol of a Phase II/III Multicentre Randomized Controlled Trial.
    van der Lei S; Dijkstra M; Nieuwenhuizen S; Schulz HH; Vos DJW; Versteeg KS; Buffart TE; Swijnenburg RJ; de Vries JJJ; Bruynzeel AME; van den Tol MP; Scheffer HJ; Puijk RS; Haasbeek CJA; Meijerink MR;
    Cardiovasc Intervent Radiol; 2023 Aug; 46(8):1076-1085. PubMed ID: 37430016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review and meta-analysis of local ablative therapies for resectable colorectal liver metastases.
    Di Martino M; Rompianesi G; Mora-Guzmán I; Martín-Pérez E; Montalti R; Troisi RI
    Eur J Surg Oncol; 2020 May; 46(5):772-781. PubMed ID: 31862133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thermal Ablation versus Stereotactic Ablative Body Radiotherapy to Treat Unresectable Colorectal Liver Metastases: A Comparative Analysis from the Prospective Amsterdam CORE Registry.
    Nieuwenhuizen S; Dijkstra M; Puijk RS; Timmer FEF; Nota IM; Opperman J; van den Bemd B; Geboers B; Ruarus AH; Schouten EAC; de Vries JJJ; Scheffer HJ; van Geel AM; van Waesberghe JHTM; Swijnenburg RJ; Versteeg KS; Lissenberg-Witte BI; van den Tol MP; Haasbeek CJA; Meijerink MR
    Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Thermal Ablation for Small-Size (0-3 cm) versus Intermediate-Size (3-5 cm) Colorectal Liver Metastases: Results from the Amsterdam Colorectal Liver Met Registry (AmCORE).
    Dijkstra M; van der Lei S; Puijk RS; Schulz HH; Vos DJW; Timmer FEF; Scheffer HJ; Buffart TE; van den Tol MP; Lissenberg-Witte BI; Swijnenburg RJ; Versteeg KS; Meijerink MR
    Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irreversible electroporation for colorectal cancer liver metastasis: a review.
    Koethe Y; Wilson N; Narayanan G
    Int J Hyperthermia; 2022; 39(1):682-687. PubMed ID: 35469520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical approach to microwave and radiofrequency liver ablation for hepatocellular carcinoma and colorectal liver metastases less than 5 cm: a systematic review and meta-analysis.
    Abdalla M; Collings AT; Dirks R; Onkendi E; Nelson D; Ozair A; Miraflor E; Rahman F; Whiteside J; Shah MM; Ayloo S; Abou-Setta A; Sucandy I; Kchaou A; Douglas S; Polanco P; Vreeland T; Buell J; Ansari MT; Pryor AD; Slater BJ; Awad Z; Richardson W; Alseidi A; Jeyarajah DR; Ceppa E
    Surg Endosc; 2023 May; 37(5):3340-3353. PubMed ID: 36542137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiofrequency and Microwave Ablation Compared to Systemic Chemotherapy and to Partial Hepatectomy in the Treatment of Colorectal Liver Metastases: A Systematic Review and Meta-Analysis.
    Meijerink MR; Puijk RS; van Tilborg AAJM; Henningsen KH; Fernandez LG; Neyt M; Heymans J; Frankema JS; de Jong KP; Richel DJ; Prevoo W; Vlayen J
    Cardiovasc Intervent Radiol; 2018 Aug; 41(8):1189-1204. PubMed ID: 29666906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SAGES/AHPBA guidelines for the use of microwave and radiofrequency liver ablation for the surgical treatment of hepatocellular carcinoma or colorectal liver metastases less than 5 cm.
    Ceppa EP; Collings AT; Abdalla M; Onkendi E; Nelson DW; Ozair A; Miraflor E; Rahman F; Whiteside J; Shah MM; Ayloo S; Dirks R; Kumar SS; Ansari MT; Sucandy I; Ali K; Douglas S; Polanco PM; Vreeland TJ; Buell J; Abou-Setta AM; Awad Z; Kwon CH; Martinie JB; Sbrana F; Pryor A; Slater BJ; Richardson W; Jeyarajah R; Alseidi A
    Surg Endosc; 2023 Dec; 37(12):8991-9000. PubMed ID: 37957297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ablation of colorectal liver metastases by irreversible electroporation: results of the COLDFIRE-I ablate-and-resect study.
    Scheffer HJ; Nielsen K; van Tilborg AA; Vieveen JM; Bouwman RA; Kazemier G; Niessen HW; Meijer S; van Kuijk C; van den Tol MP; Meijerink MR
    Eur Radiol; 2014 Oct; 24(10):2467-75. PubMed ID: 24939670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of local ablative therapies, including radiofrequency ablation, microwave ablation, stereotactic ablative radiotherapy, and particle radiotherapy, for inoperable hepatocellular carcinoma: a systematic review and meta-analysis.
    Cheng PL; Wu PH; Kao WY; Lai YT; Hsu JC; Chiou JF; Wu MH; Lee HL
    Exp Hematol Oncol; 2023 Apr; 12(1):37. PubMed ID: 37046292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal liver metastases: surgery versus thermal ablation (COLLISION) - a phase III single-blind prospective randomized controlled trial.
    Puijk RS; Ruarus AH; Vroomen LGPH; van Tilborg AAJM; Scheffer HJ; Nielsen K; de Jong MC; de Vries JJJ; Zonderhuis BM; Eker HH; Kazemier G; Verheul H; van der Meijs BB; van Dam L; Sorgedrager N; Coupé VMH; van den Tol PMP; Meijerink MR;
    BMC Cancer; 2018 Aug; 18(1):821. PubMed ID: 30111304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irreversible Electroporation to Treat Unresectable Colorectal Liver Metastases (COLDFIRE-2): A Phase II, Two-Center, Single-Arm Clinical Trial.
    Meijerink MR; Ruarus AH; Vroomen LGPH; Puijk RS; Geboers B; Nieuwenhuizen S; van den Bemd BAT; Nielsen K; de Vries JJJ; van Lienden KP; Lissenberg-Witte BI; van den Tol MP; Scheffer HJ
    Radiology; 2021 May; 299(2):470-480. PubMed ID: 33724066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorectal liver metastases: making the unresectable resectable using irreversible electroporation for microscopic positive margins - a case report.
    Schoellhammer HF; Goldner B; Merchant SJ; Kessler J; Fong Y; Gagandeep S
    BMC Cancer; 2015 Apr; 15():271. PubMed ID: 25886376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of microwave ablation versus radiofrequency ablation in the treatment of colorectal liver metastases: A systematic review and meta-analysis.
    Tang Y; Zhong H; Wang Y; Wu J; Zheng J
    Clin Res Hepatol Gastroenterol; 2023 Aug; 47(7):102182. PubMed ID: 37479137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiofrequency versus microwave ablation for intraoperative treatment of colorectal liver metastases.
    Krul MF; Gerritsen SL; Vissers FL; Klompenhouwer EG; Ruers TJ; Kuhlmann KF; Kok NF
    Eur J Surg Oncol; 2022 Apr; 48(4):834-840. PubMed ID: 34686404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of thermal ablation in the management of colorectal liver metastasis.
    Takahashi H; Berber E
    Hepatobiliary Surg Nutr; 2020 Feb; 9(1):49-58. PubMed ID: 32140478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irreversible electroporation versus radiofrequency ablation for hepatocellular carcinoma: a single centre propensity-matched comparison.
    Freeman E; Cheung W; Ferdousi S; Kavnoudias H; Majeed A; Kemp W; Roberts SK
    Scand J Gastroenterol; 2021 Aug; 56(8):942-947. PubMed ID: 34057003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence and survival following microwave, radiofrequency ablation, and hepatic resection of colorectal liver metastases: A systematic review and network meta-analysis.
    Gavriilidis P; Roberts KJ; de'Angelis N; Aldrighetti L; Sutcliffe RP
    Hepatobiliary Pancreat Dis Int; 2021 Aug; 20(4):307-314. PubMed ID: 34127382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-center nonrandomized clinical trial to assess the safety and efficacy of irreversible electroporation (IRE) ablation of liver tumors in humans: Short to mid-term results.
    Frühling P; Nilsson A; Duraj F; Haglund U; Norén A
    Eur J Surg Oncol; 2017 Apr; 43(4):751-757. PubMed ID: 28109674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.